4 minutes ago
Welllllll this was short lived. Much like AMP citrate (DMBA), DMHA as we know it has officially landed in the FDA's no fly list. For those who are not aware of what this is, here is a quick recap.
This is a sympathomimetic, like DMAA and AMP Citrate. As such it's a strong stim, though not as strong mg for mg, with a few other anecdotal twists. It can increase dopamine and adrenaline artificially which cause the rush of energy and focus. Second, the compound also decreases their breakdown/reuptake rate dopamine/adrenaline increasing the overall effect as well. Lastly this molecule is ambiphilic, so it crosses the blood-brain barrier without too much trouble.
TL;DR it's a stronger stimulant that acts on the CNS like DMAA and friends. Unfortunately it's now going to likely vanish largely from the market. The FDA doesn't like these things, or most things, but the fault absolutely lies within the industry. Supplement companies of old (and lets face it new) did some insanely dumb shit which has made the FDA the townsfolk from the fable "the boy who cried wolf". They do not trust the industry, so therefore they pull anything that even remotely looks "bad".
I personally love DMHA. Even at 200+mg I felt great and not overly cracked out. In fact BZRK by @blackmagic.supply may have cracked my favorite preworkouts of all time. I personally hate to see DMHA go; I like it better on a regular basis over DMAA and AMP Citrate.
As much as I hate government oversight on freedom of choice, I completely understand why this is happening. I think DMHA is a relatively well received ingredient with a ancedotally safe profile. But ancedtoe =/= data. It's a tough thing to see, but not a hard thing to watch happen. at Myofactor Supplements